Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01048853 · ClinicalTrials.gov registry record · NA
Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer
A NA study, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 137
- Enrollment target
NCT01048853: Clinical Trial NA study, sponsored by M.D. Anderson Cancer Center.
NCT01048853 is a NA study that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 137 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01048853, a NA study, was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 137 participants
- Enrollment target
Study Summary
This clinical trial studies conservative surgery in treating patients with low-risk stage IA2 or IB1 cervical cancer. Conservative surgery is a less invasive type of surgery for early stage cervical cancer and may have fewer side effects and improve recovery.
Primary Outcome
The proposed treatment strategy will be considered not feasible if the immediate failure rate is more than 3%. The immediate failure rate, defined as residual disease in the simple hysterectomy specimen of women who underwent conization followed by simple hysterectomy and lymph node assessment.
Interventions
- OTHER Quality-of-Life Assessment
- PROCEDURE Therapeutic Conventional Surgery
- PROCEDURE Sentinel Lymph Node Biopsy
- PROCEDURE Lymph Node Mapping
- PROCEDURE Salpingo-Oophorectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2010-04-15 |
| Est. Completion | 2025-12-05 |
| Phase | NA |
Why NCT01048853 stopped before completion
NCT01048853 is an interventional study that assigns participants to a tested intervention. The registered 137 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 5 interventions - of which Quality-of-Life Assessment is the first listed.
NCT01048853 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01048853 about?
NCT01048853 is a clinical study titled "Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer". This clinical trial studies conservative surgery in treating patients with low-risk stage IA2 or IB1 cervical cancer. Conservative surgery is a less invasive type of surgery for early stage cervical cancer and may have fewer side effects and improve recovery.
What is the current status of trial NCT01048853?
This trial is currently terminated. It is a NA study. The enrollment target is 137 participants. The study started on 2010-04-15. Estimated completion is 2025-12-05.
What interventions are being tested in trial NCT01048853?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Therapeutic Conventional Surgery (PROCEDURE), Sentinel Lymph Node Biopsy (PROCEDURE), Lymph Node Mapping (PROCEDURE), Salpingo-Oophorectomy (PROCEDURE).
Who is sponsoring clinical trial NCT01048853?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01048853's enrollment target sits among peer trials
137 722nd of 2000 higher than 1,279 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05091424 · 137 participants · Phase 1
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
- NCT05655182 · 137 participants · Phase 1
A Study of BLB-201 RSV Vaccine in Infants and Children
- NCT06571669 · 137 participants · NA
BOOM-IBD2 Pivotal Clinical Trial
- NCT06644768 · 137 participants · Phase 1
A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI